Burn-induced gut barrier injury is attenuated by phosphodiesterase inhibition: effects on tight junction structural proteins.
Loss of intestinal barrier function after burn injury allows movement of intraluminal contents across the mucosa, which can lead to the development of distant organ injury and multiple organ failure. Tight junction function is highly regulated by membrane-associated proteins including occludin and zonula occludens protein 1 (ZO-1), which can be modulated by systemic inflammation. We hypothesized that (1) burn injury leads to gut barrier injury, and (2) phosphodiesterase inhibition will attenuate these burn-induced changes. Male balb/c mice undergoing a 30% steam burn were randomized to resuscitation with normal saline or normal saline + pentoxifylline (PTX; 12.5 mg/kg). Intestinal injury was assessed by histological diagnosis and TNF-alpha levels using enzyme-linked immunosorbent assay. Intestinal permeability was assessed by measuring the plasma concentration of fluorescein isothiocyanate-dextran after intraluminal injection in the distal ileum. Occludin and ZO-1 levels were analyzed by immunoblotting and immunohistochemistry. Thirty percent total body surface area (TBSA) burn results in a significant increase in intestinal permeability. Treatment with PTX after burn attenuates intestinal permeability to sham levels. Burn injury resulted in a marked decrease in the levels of tight junction proteins occludin and ZO-1 at 6 and 24 h. The use of PTX after burn significantly decreases the breakdown of occludin and ZO-1. Pentoxifylline also attenuates the burn-induced increase in plasma and intestinal TNF-alpha. Confocal microscopy demonstrates that PTX attenuates the burn-induced reorganization of occludin and ZO-1 away from the tight junction. Pentoxifylline attenuates burn-induced intestinal permeability and decreases the breakdown and reorganization of intestinal occludin and ZO-1. Therefore, phosphodiesterase inhibition may be a useful adjunct strategy in the attenuation of burn-induced gut barrier injury.
Costantini
Todd W
TW
Division of Trauma, Surgical Critical Care, and Burns, Department of Surgery, University of California-San Diego School of Medicine, San Diego, California, USA.
Loomis
William H
WH
Putnam
James G
JG
Drusinsky
Dana
D
Deree
Jessica
J
Choi
Sunghyuk
S
Wolf
Paul
P
Baird
Andrew
A
Eliceiri
Brian
B
Bansal
Vishal
V
Coimbra
Raul
R
D000818:Animals; D002056:Burns / Q000188:drug therapy / Q000209:etiology* / Q000473:pathology / Q000503:physiopathology; D007082:Ileum / Q000187:drug effects / Q000473:pathology; D008297:Male; D008565:Membrane Proteins / Q000378:metabolism; D051379:Mice; D008807:Mice, Inbred BALB C; D018613:Microscopy, Confocal; D010431:Pentoxifylline / Q000494:pharmacology; D010539:Permeability / Q000187:drug effects; D010726:Phosphodiesterase Inhibitors / Q000627:therapeutic use*; D019108:Tight Junctions / Q000187:drug effects / Q000502:physiology*; D014409:Tumor Necrosis Factor-alpha / Q000378:metabolism
D008565:Membrane Proteins; D010726:Phosphodiesterase Inhibitors; D014409:Tumor Necrosis Factor-alpha; D010431:Pentoxifylline
J Surg Res. 2007 Nov;143(1):99-108
17950078
Gastroenterology. 2004 Jul;127(1):224-38
15236188
J Trauma. 2005 Sep;59(3):575-82
16361898
J Cell Biol. 2004 Apr 26;165(2):175-80
15096524
J Trauma. 2006 Jan;60(1):41-51
16456435
Crit Care Med. 2004 Nov;32(11):2267-73
15640640
Shock. 2005 Apr;23(4):330-6
15803056
J Burn Care Res. 2007 Jan-Feb;28(1):167-72
17211221
J Trauma. 2007 Apr;62(4):818-27; discussion 827-8
17426535
Crit Care Med. 1999 Oct;27(10):2246-51
10548215
J Trauma. 2007 Jan;62(1):104-11
17215740
Surgery. 1988 Aug;104(2):191-8
3400055
Am J Physiol Gastrointest Liver Physiol. 2004 Mar;286(3):G367-76
14766535
Shock. 2004 Mar;21(3):261-70
14770040
J Trauma. 2004 Feb;56(2):442-9
14960994
J Biol Chem. 1998 Nov 6;273(45):29745-53
9792688
Ann Surg. 1998 Oct;228(4):518-27
9790341
Shock. 1994 Apr;1(4):286-90
7735963
J Trauma. 2006 Jan;60(1):115-25
16456445
Med Electron Microsc. 2003 Sep;36(3):147-56
14505058
J Burn Care Rehabil. 2005 Jan-Feb;26(1):85-91
15640741
Surg Infect (Larchmt). 2005 Spring;6(1):73-85
15865553
J Trauma. 2008 Jan;64(1):126-30
18188110
J Trauma. 2005 Aug;59(2):257-64; discussion 264-5
16294063
Am J Surg. 1999 Dec;178(6):449-53
10670850
Gut. 2007 Jan;56(1):61-72
16822808
Crit Care Med. 2004 Feb;32(2):533-8
14758175
J Trauma. 1991 May;31(5):629-36; discussion 636-8
2030509
Br J Pharmacol. 2003 Mar;138(5):950-8
12642397
Exp Biol Med (Maywood). 2004 Jul;229(7):684-93
15229363
J Cell Biol. 1993 Dec;123(6 Pt 2):1777-88
8276896
J Immunol. 2007 Apr 1;178(7):4641-9
17372023
Arch Surg. 2003 Nov;138(11):1219-25
14609870
Immunol Rev. 1997 Apr;156:145-66
9176706
Shock. 2004 Jan;21(1):52-7
14676684